Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-01-09

Clinical Trial Update: Sperm DNA Damage in β-thalassemia Major: Is There a Role for Antioxidants? [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update investigates whether antioxidants can mitigate sperm DNA damage in men with beta-thalassemia major, spanning Phase 1 and Phase 2 stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ain Shams University | Conditions: Endocrine Disease, Fertility Decreased Male | Phase 1, Phase 2 | Status: UNKNOWN